Publications

Flum, M., S. Dicks, Y. H. Teng, M. Schrempp, A. Nystrom, M. Boerries, and A. Hecht. 2022. Canonical TGFbeta signaling induces collective invasion in colorectal carcinogenesis through a Snail1- and Zeb1-independent partial EMT. Oncogene. pii: 10.1038/s41388-022-02190-4. doi: 10.1038/s41388-022-02190-4.

Vogelmann A, Schiedel M, Wössner N, Merz A, Herp D, Hammelmann S, Colcerasa A, Komaniecki G, Hong JY, Sum M, Metzger E, Neuwirt E, Zhang L, Einsle O, Groß O, Schüle R, Lin H, Sippl W, Jung M. 2022. Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration. RSC Chem Biol 3(4):468-485. doi: 10.1039/d1cb00244a.

Erny, D., N. Dokalis, C. Mezo, O. Mossad, T. Blank, and M. Prinz. 2022. Flow-cytometry-based protocol to analyze respiratory chain function in mouse microglia. STAR Protoc 3: 101186.

Sharma, R., S. S. Sahoo, M. Honda, S. L. Granger, C. Goodings, L. Sanchez, A. Kunstner, H. Busch, F. Beier, S. M. Pruett-Miller, M. B. Valentine, A. G. Fernandez, T. C. Chang, V. Geli, D. Churikov, S. Hirschi, V. B. Pastor, M. Boerries, M. Lauten, C. Kelaidi, M. A. Cooper, S. Nicholas, J. A. Rosenfeld, S. Polychronopoulou, C. Kannengiesser, C. Saintome, C. M. Niemeyer, P. Revy, M. S. Wold, M. Spies, M. Erlacher, S. Coulon, and M. W. Wlodarski. 2022. Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue. Blood 139: 1039-1051

Schauer, F., S. Mai, S. C. Hofmann, Y. Mai, K. Izumi, J. S. Kern, and D. Kiritsi. 2022. Autoreactivity to BP180 Neoepitopes in Patients With Pemphigoid Gestationis. JAMA Dermatol 158: 212-214. doi: 10.1001/jamadermatol.2021.5294.

Aichele P, Neumann-Haefelin C, Ehl S, Thimme R, Cathomen T, Boerries M, Hofmann M. 2022. Immunopathology caused by impaired CD8+ T-cell responses. Eur J Immunol. Jan 31. doi: 10.1002/eji.202149528. Online ahead of print.

Harder, I., M. Munchhalfen, G. Andrieux, Boerries, B. Grimbacher, H. Eibel, M. E. Maccari, S. Ehl, J. Wienands, J. Jellusova, K. Warnatz, and B. Keller. 2022. Dysregulated PI3K Signaling in B Cells of CVID Patients. Cells 11:464. doi: 10.3390/cells11030464.

James AE, West L, Schloss K, Nataraj P, Urban A, Hirsch A, Krausz M, Kumar S, Raasch J, Risma K, Church JA, Grimbacher B, Bergerson JRE, Chong H, Freeman AF. 2022. Treatment of STAT3-deficient hyper-immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation. J Allergy Clin Immunol Pract. Jan 24:S2213-2198(22)00027-7.

Boeckelmann, D., M. Wolter, K. Neubauer, F. Sobotta, A. Lenz, H. Glonnegger, B. Kasmann-Kellner, J. Mann, S. Ehl, and B. Zieger. 2021. Hermansky-Pudlak Syndrome: Identification of Novel Variants in the Genes HPS3, HPS5, and DTNBP1 (HPS-7). Front Pharmacol 12: 786937. doi: 10.3389/fphar.2021.786937

Sperlich JM, Grimbacher B, Soetedjo V, Workman S, Burns SO, Lowe DM, Hurst JR. 2022. Predictive Factors for and Complications of Bronchiectasis in Common Variable Immunodeficiency Disorders. J Clin Immunol. 2022 Jan 11. doi: 10.1007/s10875-022-01206-8.

Kind F, Fassbender TF, Andrieux G, Boerries M, Meyer PT, Ruf J. 2021. Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival. Cancers (Basel). 2021 Dec 29;14(1):149. doi: 10.3390/cancers14010149.

von Schoenfeld A, Bronsert P, Poc M, Fuller A, Filby A, Kraft S, Kurowski K, Sörensen K, Huber J, Pfeiffer J, Proietti M, Stehl V, Werner M, Seidl M. 2021. Multiple Immunostainings with Different Epitope Retrievals-The FOLGAS Protocol. Int J Mol Sci. 23(1):223. doi: 10.3390/ijms23010223.

Corrales E, Levit-Zerdoun E, Metzger P, Kowar S, Ku M, Brummer T, Boerries M. 2021. Dynamic transcriptome analysis reveals signatures of paradoxical effect of vemurafenib on human dermal fibroblasts. Cell Commun Signal. 19(1):123. doi: 10.1186/s12964-021-00801-3.

Rojas-Restrepo J, Caballero-Oteyza A, Huebscher K, Haberstroh H, Fliegauf M, Keller B, Kobbe R, Warnatz K, Ehl S, Proietti M, Grimbacher B. 2021. Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study. Front Immunol. 12:786516. doi: 10.3389/fimmu.2021.786516.

Yang L, Booth C, Speckmann C, Seidel MG, Worth AJ, Kindle G, Lankester AC, B G; ESID Clinical and Registry Working Parties, Gennery AR, Seppanen MR, Morris EC, Burns SO. Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency.2021.  J Allergy Clin Immunol. S0091-6749(21)02597-5. doi: 10.1016/j.jaci.2021.10.037. Online ahead of print.

d’Errico, P., S. Ziegler-Waldkirch, V. Aires, P. Hoffmann, C. Mezo, D. Erny, L. S. Monasor, S. Liebscher, V. M. Ravi, K. Joseph, O. Schnell, K. Kierdorf, O. Staszewski, S. Tahirovic, M. Prinz, and M. Meyer-Luehmann. 2022. Microglia contribute to the propagation of Abeta into unaffected brain tissue. Nat Neurosci 25: 20-25.